Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...
An emerging field of genetics promises to let parents choose the “healthiest” baby.
A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests - Decipher, Oncotype DX Genomic Prostate Score (GPS) and Prolaris - can help doctors make better decisions ...
Gram and colleagues describe valid concerns arising from the growing market for medical direct-to-consumer (DTC) tests but do ...
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Genomic classifier (GC) tests do not appear to consistently influence risk classification or treatment decisions for ...
A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests — Decipher, Oncotype DX Genomic Prostate Score (GPS) and Prolaris — can help doctors make better decisions ...
Tissue-based genomic classifier tests, developed to improve prostate cancer risk assessment and treatment recommendations, ...
A new resource from the National Comprehensive Cancer Network (NCCN) provides evidence-based guidance on assessing and ...